Insight by Science
A penicillin allergy label causes worse health outcomes and higher mortality because clinicians avoid narrow beta-lactams and use broader, more toxic or less effective antibiotics that raise resistance, C. difficile risk, surgical infections, costs, and length of stay.
Want more like this?
Every card on Korva is an insight someone saved from a podcast or video they loved.
More from this video
See all →A reliable blood test for penicillin allergy is hard to build because allergy-specific antibody levels fall or vary over time and current assays miss many true positives, so single blood panels show low sensitivity.
Aggressive pharmaceutical marketing and regulatory relabeling can inflate perceived allergy prevalence because expanding indications, lobbying, and normalization of rescue products increase diagnoses and prescriptions, which make the condition look more common.
